Published in J Biol Chem on April 10, 1985
The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev (2010) 3.40
Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J (1997) 2.21
Biogenesis of multilamellar bodies via autophagy. Mol Biol Cell (2000) 1.54
A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J Exp Med (1996) 1.42
Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol (1995) 1.31
A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem (2010) 1.27
Molecular cloning and expression of cDNA encoding the enzyme that controls conversion of high-mannose to hybrid and complex N-glycans: UDP-N-acetylglucosamine: alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I. Proc Natl Acad Sci U S A (1991) 1.19
Ras (proto)oncogene induces N-linked carbohydrate modification: temporal relationship with induction of invasive potential. EMBO J (1988) 1.02
Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein. Biochem J (1992) 0.99
Glycosylation in bladder cancer. Int J Clin Oncol (2008) 0.99
Alterations in carbohydrate composition of serum IgG from patients with rheumatoid arthritis and from pregnant women. Ann Rheum Dis (1988) 0.99
A retrospective and prospective view of glycopathology. Glycoconj J (1998) 0.98
A journey to the world of glycobiology. Glycoconj J (2001) 0.98
Probing the substrate specificity of Golgi alpha-mannosidase II by use of synthetic oligosaccharides and a catalytic nucleophile mutant. J Am Chem Soc (2008) 0.97
NMR structural characterization of substrates bound to N-acetylglucosaminyltransferase V. J Mol Biol (2006) 0.96
Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer. Front Oncol (2015) 0.91
Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide beta(1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential. Glycoconj J (1997) 0.90
Terminal glycosylation and disease: influence on cancer and cystic fibrosis. Glycoconj J (2001) 0.88
Decreased tumorigenicity correlates with expression of altered cell surface carbohydrates in Lec9 CHO cells. Mol Cell Biol (1986) 0.88
Isolation and partial characterization of ascites sialoglycoprotein-2 of the cell surface sialomucin complex of 13762 rat mammary adenocarcinoma cells. Biochem J (1990) 0.86
Control of carbohydrate processing: increased beta-1,6 branching in N-linked carbohydrates of Lec9 CHO mutants appears to arise from a defect in oligosaccharide-dolichol biosynthesis. Mol Cell Biol (1989) 0.85
A novel second isoenzyme of the human UDP-N-acetylglucosamine:alpha1,3-D-mannoside beta1,4-N-acetylglucosaminyltransferase family: cDNA cloning, expression, and chromosomal assignment. Glycoconj J (1998) 0.84
Disruption of oligosaccharide processing in murine tumor cells inhibits their susceptibility to lysis by activated mouse macrophages. Proc Natl Acad Sci U S A (1986) 0.83
Suppression of cancer progression by MGAT1 shRNA knockdown. PLoS One (2012) 0.81
Carbohydrate-based cancer vaccines: target cancer with sugar bullets. Glycoconj J (2012) 0.80
GnT-V, macrophage and cancer metastasis: a common link. Clin Exp Metastasis (2003) 0.79
Enhanced expression of the β4-galactosyltransferase 2 gene impairs mammalian tumor growth. Cancer Gene Ther (2014) 0.78
Functional aspects of glycoprotein N-linked oligosaccharide processing by human tumours. Br J Cancer Suppl (1990) 0.77
Cytochemical staining for beta 1,6 branching of asparagine-linked oligosaccharides in variants of metastatic human colon carcinoma cells. Am J Pathol (1994) 0.77
Regulation of expression of the human beta-1,2-N-acetylglucosaminyltransferase II gene (MGAT2) by Ets transcription factors. Biochem J (2000) 0.77
Challenge to the suppression of tumor growth by the β4-galactosyltransferase genes. Proc Jpn Acad Ser B Phys Biol Sci (2015) 0.75
Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science (1992) 6.40
Antitumor agents. 203. Carbazole alkaloid murrayaquinone A and related synthetic carbazolequinones as cytotoxic agents. J Nat Prod (2000) 3.62
The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2. EMBO J (1993) 3.03
Loss of RCC1, a nuclear DNA-binding protein, uncouples the completion of DNA replication from the activation of cdc2 protein kinase and mitosis. EMBO J (1991) 2.86
Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells (1997) 2.72
A short timescale for terrestrial planet formation from Hf-W chronometry of meteorites. Nature (2002) 2.54
Improved results of atherosclerotic arch aneurysm operations with a refined technique. J Thorac Cardiovasc Surg (2001) 2.53
Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J Biol Chem (1997) 2.38
Lung nodule enhancement at CT: multicenter study. Radiology (2000) 2.32
Use of endo- and exoglycosidases for structural studies of glycoconjugates. Anal Biochem (1979) 2.31
Structural studies of two ovalbumin glycopeptides in relation to the endo-beta-N-acetylglucosaminidase specificity. J Biol Chem (1975) 2.23
The transcriptional elongation inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J Biol Chem (1995) 2.22
Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett (1992) 2.21
Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut (2007) 2.15
Purification and characterization of normal and mutant forms of T4 endonuclease V. J Biol Chem (1982) 2.14
In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins. Antimicrob Agents Chemother (1991) 2.08
Surveillance of viral gastroenteritis in Japan: pediatric cases and outbreak incidents. J Infect Dis (2000) 2.04
Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis. J Bacteriol (1997) 2.01
A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem (1989) 1.92
Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice. Antimicrob Agents Chemother (1992) 1.89
The substrate specificities of endo-beta-N-acetylglucosaminidases CII and H. Biochem Biophys Res Commun (1977) 1.87
Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci (1994) 1.86
Laparoscopic repair of a paraduodenal hernia. Surg Endosc (1998) 1.84
Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem (1992) 1.82
Total arch replacement using aortic arch branched grafts with the aid of antegrade selective cerebral perfusion. Ann Thorac Surg (2000) 1.82
A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy. Am J Transplant (2009) 1.81
Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives. Chem Pharm Bull (Tokyo) (1993) 1.80
Fractionation of glycopeptides by affinity column chromatography on concanavalin A-sepharose. J Biochem (1975) 1.72
New electrophysiologic features and catheter ablation of atrioventricular and atriofascicular accessory pathways: evidence of decremental conduction and the anatomic structure of the Mahaim pathway. J Cardiovasc Electrophysiol (1998) 1.72
Antitumor agents. 181. Synthesis and biological evaluation of 6,7,2',3',4'-substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a new class of antimitotic antitumor agents. J Med Chem (1998) 1.71
Role of biologic glue repair of proximal aortic dissection in the development of early and midterm redissection of the aortic root. Ann Thorac Surg (2001) 1.70
Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry (1989) 1.69
Characteristics of polarographic catalytic waves observed with bovine-serum albumin: kinetic or diffusion control. Proc Natl Acad Sci U S A (1973) 1.65
Analysis of oligosaccharides by gel filtration. Methods Enzymol (1982) 1.64
A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol (1990) 1.64
Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body. Am J Physiol (1992) 1.63
Nasal reconstruction based on aesthetic subunits in Orientals. Plast Reconstr Surg (2000) 1.60
Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci U S A (1999) 1.60
Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect Immun (1990) 1.60
Life-threatening hyperkalaemia caused by angiotensin-converting enzyme-inhibitor and diuretics. Diabet Med (1997) 1.58
p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am J Clin Pathol (2001) 1.58
Detection of O-mannosyl glycans in rabbit skeletal muscle alpha-dystroglycan. Biochim Biophys Acta (1998) 1.55
Hydrazinolysis of asparagine-linked sugar chains to produce free oligosaccharides. Methods Enzymol (1982) 1.54
A case of cluster headache associated with mitochondrial DNA deletions. Muscle Nerve (1997) 1.53
Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: a prospective randomized study. Gastrointest Endosc (1999) 1.53
The prognosis of surgery for cervical compression myelopathy. An analysis of the factors involved. J Bone Joint Surg Br (1989) 1.53
Myelopathy hand. New clinical signs of cervical cord damage. J Bone Joint Surg Br (1987) 1.53
Lung nodules: dual-kilovolt peak analysis with CT--multicenter study. Radiology (2000) 1.49
The structures of the galactose-containing sugar chains of ovalbumin. J Biol Chem (1978) 1.47
Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. J Immunol (1982) 1.47
Gender effects on age-related changes in brain structure. AJNR Am J Neuroradiol (2000) 1.44
Evaluation of diffusivity in the anterior lobe of the pituitary gland: 3D turbo field echo with diffusion-sensitized driven-equilibrium preparation. AJNR Am J Neuroradiol (2013) 1.43
Pathogenesis of retinoic acid-induced abnormal pad patterns on mouse volar skin. Teratology (2000) 1.43
GC/MS analysis of urinary excretion of 9alpha,11beta-PGF2 in acute and exercise-induced asthma in children. Clin Exp Allergy (1998) 1.42
Experimental study on the effect of antegrade cerebral perfusion on brains with old cerebral infarction. J Thorac Cardiovasc Surg (2001) 1.41
Obvious mRNA and protein expression but absence of mutations of the RET proto-oncogene in parathyroid tumors. Eur J Endocrinol (1996) 1.40
Activated protein C resistance and Japanese NIDDM patients with coronary heart disease. Diabetes Care (1997) 1.40
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum. J Nat Prod (2001) 1.39
Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci (1993) 1.36
Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem Biophys Res Commun (1990) 1.36
Characteristics of polarographic catalytic waves observed with bovine-serum albumin: effects of type of buffers, pH, ionic strength, calcium, and tetraalkyl salts. Proc Natl Acad Sci U S A (1974) 1.36
Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun (1991) 1.32
Cerebellar hemorrhage after supratentorial craniotomy--report of three cases. Neurol Med Chir (Tokyo) (1990) 1.31
The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res (1997) 1.31
Prognostic significance of intramural metastasis in patients with esophageal carcinoma. Cancer (1990) 1.31
Thoracic myelopathy secondary to ossification of the spinal ligament. J Neurosurg (1987) 1.29
Structure of the carbohydrate moieties of bovine rhodopsin. J Biol Chem (1979) 1.29
Fractionation of L-fucose-containing oligosaccharides on immobilized Aleuria aurantia lectin. J Biol Chem (1985) 1.26
Cell cycle regulation of the p34cdc2/p33cdk2-activating kinase p40MO15. J Cell Sci (1994) 1.25
Structures of the carbohydrate moiety of ovalbumin glycopeptide III and the difference in specificity of endo-beta-N-acetylglucosaminidases CII and H. J Biol Chem (1977) 1.25
Microdetermination of sugar composition by radioisotope labeling. Methods Enzymol (1978) 1.25
Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency. J Biol Chem (1993) 1.24
Causes of neurologic deterioration following surgical treatment of cervical myelopathy. Spine (Phila Pa 1976) (1986) 1.24
MDM2 and MDMX bind and stabilize the p53-related protein p73. Curr Biol (1999) 1.24
Structure, biosynthesis and functions of glycoprotein glycans. Experientia (1982) 1.24
Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol (2008) 1.24
Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem Biophys Res Commun (1990) 1.23
Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells. J Biol Chem (1988) 1.23
IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology (1991) 1.23
Structural study of the carbohydrate moiety of bovine pancreatic ribonuclease B. J Biochem (1980) 1.23
Endometrial cysts: diagnosis with MR imaging. Radiology (1991) 1.22
Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles. J Med Chem (1999) 1.22
The asparagine-linked sugar chains of subcomponent C1q of the first component of human complement. J Biol Chem (1978) 1.22
An enzymic basis for blood type A in humans. Arch Biochem Biophys (1968) 1.22
Elevation of cyclic guanosine 3',5'-monophosphate levels in dog thyroid slices caused by acetylcholine and sodium fluoride. J Biol Chem (1972) 1.22
New structural characteristic of the large glycopeptides from transformed cells. Nature (1976) 1.21
Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J Biol Chem (1984) 1.21